The Journal of Organic Chemistry
Article
saturated aqueous NH4Cl solution. The aqueous layer was extracted
three times with AcOEt, and the combined organic layers were washed
with brine, dried over Na2SO4, and concentrated in vacuo. The residue
was purified by silica gel chromatography (n-hexane/AcOEt = 10: 1 →
5:1) to afford 9 (266 mg, 83%): yellow needles; mp 164−165 °C; 1H
NMR (pyridine-d5) δ 8.86 (br, 1H), 8.75 (d, J = 8.3 Hz, 1H), 8.35 (s,
2H), 8.02 (d, J = 8.0 Hz, 2H), 7.99 (br, 1H), 7.70 (s, 1H), 7.63 (d, J =
7.7 Hz, 1H) 7.33−7.55 (m, 8H), 7.04 (dd, J = 7.7 Hz, 1H) ppm (two
peaks could not be observed); 13C NMR (pyridine-d5) δ 186.7, 184.0,
152.3, 141.8, 140.7, 137.2, 133.8, 132.6, 131.9, 131.5, 131.3, 131.0,
130.8, 129.9, 128.9, 128.5, 128.4, 127.0. 126.6, 124.5, 123.2, 123.1,
122.4, 122.3, 122.1, 120.1, 119.0, 118.4, 114.8, 111.2, 96.5, 94.9, 90.2
ppm; IR (ATR) 3332, 2208, 1688, 1661, 1597 cm−1; MS (FAB) 595
(MH+, 45) 105 (100); HRMS (ESI) calcd for C32H21F6N2O3 (MH+)
595.1451, found 595.1453.
Reaction of Binary-Complex Models 11 and 12. General
Procedure. To a solution of 11 or 12 (1.0 equiv) in CD2Cl2
appropriate electrophile was added (1.5 equiv) at room temperature.
After being stirred at room temperature for 10 or 30 min, the mixture
was purified by silica gel chromatography (CHCl3/MeOH). A general
procedure afforded 14 (67%, 100% conversion)*: yellow amorphous
solid; 1H NMR (CDCl3) δ: 8.49 (0.6H, d, J = 8.3 Hz), 8.44 (0.4H, d, J
= 8.6 Hz), 8.04−7.98 (1H, br m), 7.92−7.84 (3H, m), 7.72−7.47 (3H,
m), 7.40−6.83 (11H, m), 6.45−5.92 (2H, m), 5.54−5.58 (0.6H, br
m), 5.51−5.53 (0.4H, br m), 3.78−3.74 (1H, m), 2.77−2.52 (1H, m),
2.25−1.70 (5H, m), 2.35 (3.6H, s), 2.20 (2.4H, s), 1.50−1.10 (4H, m),
1.25 (3.6H, s), 1.22 (5.4 H, s) ppm; HRMS (FAB) calcd for
C44H49N4O5 (MH+) 713.3703, found 713.3712. *Mixture of
diastreomers (60:40).
Methyl 2-[[(tert-Butoxycarbonyl)amino](phenyl)methyl)-8-[[2-[3-
[(1R,2R)-2-(dimethylamino)cyclohexyl]ureido]phenyl]ethynyl]-1-
oxo-1,2,3,4-tetrahydronaphthalene-2-carboxylate (15). A general
Methyl 8-[[2-[3-[3,5-Bis(trifluoromethyl)phenyl]ureido]phenyl]-
ethynyl]-1-oxo-1,2,3,4-tetrahydronaphthalene-2-carboxylate (10).
A procedure similar to that described for the preparation of 9 afforded
procedure afforded 15 (77%, 100% conversion): yellow amorphous;
1
1
[α]25 +88.4 (c 1.12, CHCl3); H NMR (CDCl3) δ 8.54 (1H, d, J =
D
10 (152 mg, 60%): yellow prisms; mp 178−179 °C; H NMR (500
8.6 Hz), 8.49 (1H, s), 7.55 (1H, d, J = 7.7 Hz), 7.48 (1H, d, J = 7.7
Hz), 7.46−7.44 (1H, m), 7.38 (2H, d, J = 7.4 Hz), 7.32−7.24 (5H, m),
6.92 (1H, td, J = 7.5, 1.1 Hz), 6.54 (1H, br s), 6.07 (1H, br s), 5.54
(1H, br s), 3.86−3.84 (1H, br m), 3.72 (3H, s), 3.25−3.00 (3H, m),
2.76−2.70 (1H, m), 2.32 (6H, s), 2.26−2.24 (2H, m), 2.00−1.65 (3H,
m), 1.40−1.25 (4H, m), 1.25 (9H, s) ppm; 13C NMR (CDCl3) δ
194.2, 170.6, 155.5, 155.2, 143.4, 143.0, 137.8, 133.0, 131.9, 130.3,
130.2, 128.9, 128.5 (×2), 128.3, 127.9, 123.8, 120.7, 118.2, 110.2, 95.7,
91.5, 79.9, 65.0, 63.0, 55.6, 52.8, 51.5, 40.3, 34.1, 28.1, 27.9, 27.2, 25.8,
25.3 (×2) ppm; IR (ATR) 3393, 3339, 2200, 1733, 1664, 1525 cm−1;
MS (FAB) 693 (MH+, 87), 57 (100); HRMS (FAB) calcd for
C41H49N4O6 (MH+) 693.3652, found 693.3647.
Di-tert-butyl 1-[(S)-8-[[2-[3-[(1R,2R)-2-(Dimethylamino)-
cyclohexyl]ureido]phenyl]ethynyl]-2-(methoxycarbonyl)-1-oxo-
1,2,3,4-tetrahydronaphthalen-2-yl]hydrazine-1,2-dicarboxylate)
(17). A general procedure afforded 17 (96%, 100% conversion): yellow
amorphous; [α]25D +9.4 (c 0.80, CHCl3); 1H NMR (CDCl3, 60 °C) δ
8.63 (1H, s), 8.48 (1H, d, J = 8.0 Hz), 7.48−7.39 (3H, m), 7.32−7.23
(2H, m), 6.89 (1H, t, J = 7.4 Hz), 5.59 (1H, br s), 3.85 (3H, s), 3.84−
3.82 (1H, m), 3.68−3.60 (1H, m), 3.36−3.20 (1H, br m), 3.04−2.98
(1H, m), 2.95−2.91 (1H, m), 2.72−2.66 (1H, m), 2.27−2.23 (1H, m),
2.26 (6H, s), 1.97−1.92 (1H, m), 1.84−1.80 (1H, m), 1.73−1.68 (1H,
m), 1.44 (9H, s), 1.42−1.15 (4H, m), 1.14 (9H, s) ppm (one peak of
NH proton could not be observed); 13C NMR (CDCl3, 60 °C) δ
190.7, 170.3, 155.3, 154.8, 147.2, 142.9, 133.0, 132.4, 131.4, 130.2,
130.1, 128.5, 124.2, 120.7, 118.6, 110.6, 95.6, 91.8, 82.6, 80.6, 76.6,
64.0, 52.9, 52.2, 39.9, 34.3, 30.3, 28.1, 27.9, 26.2, 25.6, 25.5, 21.8 ppm
(one peak could not be observed); IR (ATR) 3407, 3346, 2933, 1747.
1717, 1671, 1524 cm−1; MS (FAB) 718 (MH+, 100); HRMS (ESI)
calcd for C39H52N5O8 (MH+) 718.3810, found 718.3809.
MHz, CDCl3) δ 9.24 (s, 1H), 8.73 (s, 1H), 8.50 (d, J = 8.3 Hz, 1H),
8.16 (s, 2H), 7.48−7.61 (m, 4H), 7.37 (dd, J = 7.9 Hz, 1H), 7.29 (d, J
= 8.5 Hz, 1H), 7.01 (dd, J = 8.5 Hz, 1H), 3.78 (1H, dd, J = 9.2, 5.2
Hz), 3.64 (3H, s), 3.22−3.20 (1H, m), 3.10−3.04 (1H, m), 2.59−2.56
(1H, m), 2.48−2.43 (1H, m) ppm; 13C NMR δ 194.9, 169.6, 152.4,
145.9, 142.1, 140.8, 133.9, 133.4, 132.3, 132.0, 131.8, 131.7, 131.5,
130.7, 130.5, 128.9, 124.4, 123.7, 122.3, 122.0, 119.2,
118.1,117.5,115.7, 110.7, 96.4, 91.6, 55.1, 52.6, 28.2, 25.8 (one peak
could not be observed) ppm; IR (ATR) 3354, 2361, 1743, 1659, 1574
cm−1; MS (FAB) 575 (MH+, 100); HRMS (FAB) calcd for
C29H21F6N2O4 (MH+) 575.1406, found 575.1402.
1-[(1R,2R)-2-(Dimethylamino)cyclohexyl]-3-[2-[[2-(3-oxo-3-
phenylpropanoyl)phenyl]ethynyl]phenyl]urea (15). A procedure
similar to that described for the preparation of 9 afforded 11 (132
mg, 75%): pale yellow prisms; mp 170−171 °C; [α]25D −23.5 (c 0,08,
CHCl3); 1H NMR (CDCl3) δ 8.20 (s, 1H), 8.13 (br, 1H), 8.02 (d, J =
8.3 Hz, 1H), 7.88 (d, J = 6.9 Hz, 2H), 7.60 (d, J = 7.8 Hz, 2H), 7.45−
7.31 (m, 6H), 7.28−7.24 (m, 1H) 6.88 (dd, J = 7.5, 7.5 Hz, 1H), 6.31
(br, 1H), 5.01 (br, 1H), 3.78−3.75 (m, 1H), 3.49−3.46 (m, 1H), 2.52
(s, 6H), 2.52−2.46 (m, 1H), 2.05−1.80 (m, 3H), 1.56−1.30 (m, 4H)
ppm (one peak of ammonium proton could not be observed); 13C
NMR (CDCl3) δ 188.5, 184.1, 155.8, 145.4, 142.3, 140.4, 132.6, 132.4,
131.0, 130.6, 129.4, 128.7, 128.1, 127.8, 127.2, 127.0, 120.9, 118.6,
111.2, 96.8, 95.0, 89.2, 65.6, 51.1, 38.9, 33.6, 24.9, 24.5, 22.5 ppm; IR
(ATR) 3265, 2144, 1783, 1686, 1601 cm−1; MS (FAB) 508 (MH+,
45), 136 (100); HRMS (FAB) calcd for C32H34N3O3 (MH+)
508.2595, found 508.2598.
Methyl 8-[[2-[3-[(1R,2R)-2-(Dimethylamino)cyclohexyl]ureido]-
phenyl]ethynyl]-1-oxo-1,2,3,4-tetrahydronaphthalene-2-carboxy-
late (12). A procedure similar to that described for the preparation of
(S)-Di-tert-butyl 1-[8-Iodo-2-(methoxycarbonyl)-1-oxo-1,2,3,4-
tetrahydronaphthalen-2-yl]hydrazine-1,2-dicarboxylate (19).20 To
a solution of 8 (1.0 equiv) and catalyst (0.1 equiv) in CH2Cl2 was
added 16 (2.0 equiv) at an appropriate temperature. After being stirred
at room temperature for 12 h, the mixture was concentrated in vacuo.
The residue was purified by silica gel chromatography (n-hexane/
1
9 afforded 12 (76 mg, 85%): yellow solid; mp 70−71 °C; H NMR
(CDCl3)* major isomer 8.95 (1H, br s), 8.53 (1H, dd, J = 9.0 Hz),
7.58−7.56 (1H, m), 7.50−7.48 (1H, m), 7.44−7.43 (1H, m), 7.33−
7.31 (1H, m), 7.27−7.24 (1H, m), 6.90−6.89 (1H, m), 6.47 (1H, d, J
= 6.6 Hz), 3.78−3.76 (2H, m), 3.77 (3H, s), 3.14−3.12 (1H, m),
3.04−3.00 (1H, m), 2.61−2.23 (4H, m), 2.30 (6H, s), 1.87−1.80 (2H,
AcOEt = 7:1): white solid; mp 61−62 °C; [α]25 +10.6 (53% ee, c
D
1
0.74, CHCl3); 1H NMR (CDCl3, 60 °C) δ 7.86−7.81 (1H, br m), 7.23
(1H, d, J = 7.4 Hz), 7.01 (1H, t, J = 7.4 Hz), 6.46 (1H, br s), 3.85 (3H,
s), 3.50−3.40 (1H, br m), 3.12−3.05 (1H, br m), 2.98−2.93 (1H, m),
2.66−2.60 (1H, m), 1.44 (9H, s), 1.25 (9H, s) ppm; 13C NMR
(CDCl3, 60 °C) δ 189.7, 170.1, 155.6, 146.1, 140.5, 132.8, 128.8, 93.9,
87.6, 83.0, 81.1, 76,2, 52.7, 30.7, 28.2, 28.0, 27.9, 26.3 ppm; IR (ATR)
3309, 2979, 1721 cm−1; MS (FAB) 561 (MH+, 11), 449 (100); HRMS
(FAB) calcd for C22H30IN2O7 (MH+) 561.1098, found 561.1102;
HPLC [Chiralpak AD, n-hexane/2-propanol = 95/5, 1.0 mL/min, λ =
254 nm, retention times: (major) 15.8 min (minor) 35.2 min].
(S)-Methyl 2-[(R)-[(tert-Butoxycarbonyl)amino](phenyl)methyl]-
8-iodo-1-oxo-1,2,3,4-tetrahydronaphthalene-2-carboxylate (22).22
To a solution of 8 (1.0 equiv) and catalyst (0.1 equiv) in CH2Cl2
was added 13 (1.2 equiv) at an appropriate temperature. After being
stirred at room temperature for 12 h, the mixture was concentrated in
m), 1.79−1.77 (1H, m), 1.27−1.15 (4H, m) ppm; minor isomer H
NMR (CDCl3) δ 8.87 (1H, br s), 8.51 (1H, d, J = 8.9 Hz), 7.58−7.56
(1H, m), 7.50−7.48 (1H, m), 7.44−7.43 (1H, m), 7.33−7.31 (1H, m),
7.27−7.24 (1H, m), 6.90−6.89 (1H, m), 6.31 (1H, d, J = 6.6 Hz),
3.78−3.76 (2H, m), 3.77 (3H, s), 3.14−3.12 (1H, m), 3.04−3.00 (1H,
m), 2.61−2.23 (4H, m), 2.30 (6H, s), 1.87−1.80 (2H, m), 1.79−1.77
(1H, m), 1.27−1.15 (4H, m) ppm; 13C NMR (CDCl3) δ 193.7, 193.1,
170.0, 155.5, 145.4, 144.9, 143.6, 143.5, 133.4, 133.3, 133.1, 132.9,
131.6, 131.5, 130.9, 130.6, 130.5, 130.4, 128.6, 128.5, 124.1, 123.7,
120.4, 120.4, 117.6, 117.5, 109.7, 109.7, 96.0, 95.7, 92.2, 91.9, 66.2,
66.0, 54.9, 54.8, 52.7, 52.6, 51.0, 50 0.8, 46.1, 40.3, 40.3, 34.1, 34.0,
28.0, 27.9, 26.0, 25.9, 25.3, 25.2, 24.9, 23.1, 22.8 ppm; IR (ATR) 3336,
2932, 2361, 1741, 1667, cm−1; MS (FAB) 488 (MH+, 100); HRMS
(FAB) calcd for C29H34N3O4 (MH+) 488.2549, found 488.2550.
*Mixture of diastereomers.
1814
dx.doi.org/10.1021/jo4028775 | J. Org. Chem. 2014, 79, 1805−1817